James N. Campbell

James N. Campbell

78 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

James N.
Campbell
is the founder of Centrexion Therapeutics Corp.
(founded in 2013) where he holds the title of President, Chief Scientific Officer & Director.
He was also the founder of Arcion Therapeutics LLC (founded in 2007) where he held the title of President & Chief Executive Officer until 2013.
Dr. Campbell is currently the Chief Executive Officer of Vallinex, Inc., a Director at CNS Therapeutics, Inc., and a Neurosurgery Professor at The Johns Hopkins University.
He previously served as a Director at Anesiva, Inc. from 2007 to 2008, a Director at Detroit Trading Co., President of the American Pain Society, and an Executive-in-Residence at Interwest Venture Management Co. Dr. Campbell obtained a doctorate degree from Yale University and an undergraduate degree from the University of Michigan.
Dr. Campbell is also the founder of Amplimmune, Inc., American Pain Foundation, Inc...

Aktive Positionen von James N. Campbell

UnternehmenPositionBeginn
CENTREXION THERAPEUTICS CORPORATION Gründer 01.02.2013
Corporate Officer/Principal -
Direktor/Vorstandsmitglied 29.11.2010
Vorstandsvorsitzender 19.01.2012

Ehemalige bekannte Positionen von James N. Campbell

UnternehmenPositionEnde
Direktor/Vorstandsmitglied 19.12.2008
Präsident -
Direktor/Vorstandsmitglied -
Gründer -
Gründer -
Sehen Sie sich die Erfahrung von James N. Campbell im Detail an

Ausbildung von James N. Campbell

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

88

Beziehungen ersten Grades

13

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Finance

Technology Services

Health Technology

  1. Börse
  2. Insiders
  3. James N. Campbell